Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 50 mg/1 | CAPSULE, LIQUID FILLED | ORAL | 35916-1654 |
| 50 mg/1 | CAPSULE, LIQUID FILLED | ORAL | 0363-0795 |
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Pamabrom, you must consult a qualified healthcare professional.
Detailed information about Pamabrom
Pamabrom is a mild xanthine-derivative diuretic primarily used in over-the-counter formulations to relieve bloating, water weight gain, and swelling associated with premenstrual syndrome (PMS).
For the relief of symptoms related to water retention and bloating, the standard adult dosage of Pamabrom is as follows:
Patients with significant renal impairment (kidney disease) should use Pamabrom with extreme caution. Since the drug and its metabolites are cleared by the kidneys, impaired function can lead to drug accumulation. Patients with a GFR (Glomerular Filtration Rate) below 30 mL/min should consult a physician before use.
Because Pamabrom is metabolized in the liver, individuals with severe hepatic dysfunction (such as cirrhosis) may experience prolonged half-lives. While specific dose-adjustment scales are not standardized for Pamabrom, starting with the lowest possible dose (25 mg) is advisable.
Geriatric patients may be more sensitive to the diuretic effects of Pamabrom. There is an increased risk of dehydration and electrolyte disturbances in this population. Monitoring for dizziness or low blood pressure is essential.
If you miss a dose of Pamabrom, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular timing. Do not double the dose to 'catch up,' as this increases the risk of side effects.
Signs of a Pamabrom overdose may include:
In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Treatment is generally supportive, focusing on hydration and electrolyte replacement.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Always read the 'Drug Facts' label on OTC products carefully.
Most individuals tolerate Pamabrom well, but as with any medication that alters fluid balance, side effects can occur. The most frequent include:
Pamabrom is a mild medication, but it must be used with an understanding of its effects on fluid balance. The most important safety consideration is maintaining adequate hydration. Diuretics work by removing water from the body; if you do not replace the water you are losing, you risk dehydration and kidney stress. Additionally, Pamabrom should not be used as a weight-loss aid. Any weight lost while taking Pamabrom is 'water weight' and will return once the medication is stopped.
No FDA black box warnings for Pamabrom. It is an OTC-monographed ingredient with a long history of safe use in the general population.
While Pamabrom is mild, it should never be combined with certain medications due to the risk of severe reactions:
Pamabrom must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a doctor include:
Pamabrom is generally classified as FDA Pregnancy Category C. This means that animal reproduction studies have not been conducted, and there are no adequate and well-controlled studies in humans. It is not known whether Pamabrom can cause fetal harm when administered to a pregnant woman. Because Pamabrom is used for PMS symptoms—which do not occur during pregnancy—there is rarely a clinical reason to use it while pregnant. If you discover you are pregnant while taking a product containing Pamabrom, discontinue use and consult your obstetrician.
It is known that xanthine derivatives (like theophylline and caffeine) are excreted into human breast milk. While there is limited data specifically on Pamabrom, it is likely that small amounts pass to the nursing infant. This could potentially cause irritability, poor sleep patterns, or increased bowel movements in the baby. Use during breastfeeding is generally discouraged unless deemed necessary by a healthcare provider. If used, monitor the infant for signs of restlessness.
Pamabrom is approved for use in children aged 12 and older, primarily for the management of menstrual-related water retention. It has not been studied in children under 12. Because the underlying condition it treats (menstrual bloating) is not present in pre-pubescent children, there is no established indication for this age group. Parents should ensure that adolescents do not exceed the adult maximum dose.
Pamabrom is a combination of 8-bromotheophylline and 2-amino-2-methyl-1-propanol. The primary mechanism of action is mediated by the 8-bromotheophylline component. Like other xanthines, it acts as a competitive antagonist at adenosine receptors (A1 and A2 subtypes). By blocking adenosine, Pamabrom prevents the constriction of the renal afferent arterioles. This results in increased renal blood flow and an elevated glomerular filtration rate (GFR). Additionally, it inhibits the tubular reabsorption of sodium (Na+) and chloride (Cl-) ions in the proximal tubules of the nephron. This creates an osmotic gradient that pulls water into the tubule for excretion, resulting in diuresis.
The pharmacodynamic effect of Pamabrom is a relatively gentle increase in urine volume. Unlike loop diuretics that act on the thick ascending limb of the Loop of Henle, Pamabrom’s effect is more proximal and less aggressive. The onset of action is typically within 30 to 60 minutes, with the peak diuretic effect occurring between 2 and 4 hours post-ingestion. The duration of effect lasts approximately 6 hours, which is why the dosing interval is set at 6-hour increments.
| Parameter | Value |
Common questions about Pamabrom
Pamabrom is primarily used as a mild diuretic to treat symptoms of water retention associated with premenstrual syndrome (PMS) and menstruation. It helps reduce common complaints such as bloating, swelling, and temporary water-weight gain. By increasing the frequency of urination, it allows the body to shed excess fluid that often accumulates due to hormonal shifts. It is frequently found in combination over-the-counter products that also contain pain relievers like acetaminophen. While effective for minor swelling, it is not intended for severe edema caused by heart or kidney failure.
The most common side effect of Pamabrom is a noticeable increase in the frequency and volume of urination, which is the drug's intended purpose. Some users may also experience mild 'caffeine-like' effects, such as jitteriness, restlessness, or difficulty sleeping if taken late in the evening. Mild stomach upset or nausea can occur in some individuals, especially if taken on an empty stomach. Because it is often paired with other ingredients in OTC meds, users might also notice changes in urine color (usually to a bright yellow). Most of these effects are temporary and resolve once the medication is stopped.
It is generally advised to limit or avoid alcohol while taking Pamabrom. Alcohol itself acts as a diuretic, and combining it with Pamabrom can increase the risk of dehydration and electrolyte imbalances. Furthermore, both substances can cause dizziness or lightheadedness; taking them together may significantly increase the risk of fainting or falls. Alcohol can also irritate the stomach lining, which may worsen any gastrointestinal side effects caused by the medication. If you choose to drink, do so in moderation and ensure you are drinking plenty of water.
Pamabrom is categorized as FDA Pregnancy Category C, meaning its safety during pregnancy has not been established through rigorous human clinical trials. Since Pamabrom is used to treat menstrual symptoms which do not occur during pregnancy, there is almost no clinical reason to take it while pregnant. If you are pregnant or planning to become pregnant, you should avoid using Pamabrom unless specifically instructed by your doctor. Potential risks to the developing fetus are unknown, and other methods of managing fluid retention during pregnancy are usually preferred. Always consult your obstetrician before taking any new medication.
Pamabrom typically begins to work within 30 to 60 minutes after oral administration. You will likely notice an increased urge to urinate within this first hour. The peak effect of the medication, where the diuresis is most pronounced, usually occurs between 2 and 4 hours after the dose is taken. Because the effects last for about 6 hours, the medication is usually dosed four times a day to maintain consistent relief from bloating. If you do not notice a reduction in swelling after several doses, you should consult a healthcare provider.
Yes, you can typically stop taking Pamabrom suddenly without experiencing withdrawal symptoms, as it is intended for short-term, cyclical use. Since it is most often used for only 5 to 7 days during a menstrual cycle, the body does not develop a physical dependence on it. However, if you have been using it daily for an extended period (which is not recommended), stopping suddenly might result in a temporary return of water retention as your body readjusts its fluid balance. Always follow the package directions and use the medication only when symptoms are present.
If you miss a dose of Pamabrom, take it as soon as you remember to help maintain the diuretic effect. If it is nearly time for your next scheduled dose, skip the missed one and continue with your regular dosing schedule. Never take two doses at once to make up for a missed one, as this can increase the risk of side effects like heart palpitations or dehydration. Since Pamabrom is used on an 'as-needed' basis for symptoms, missing a single dose may simply result in a temporary return of bloating until the next dose is taken.
No, Pamabrom does not cause weight gain; in fact, it is specifically designed to help with temporary water-weight loss. The weight lost while taking Pamabrom is entirely due to the excretion of excess water through urine. It is important to note that this is not a treatment for fat loss or long-term weight management. Once you stop taking the medication and your menstrual cycle ends, your body's fluid levels will return to normal. If you experience sudden, unexplained weight gain while taking the drug, you should contact a doctor, as this could indicate a more serious underlying health issue.
Pamabrom can interact with several types of medications, so caution is necessary. It should not be taken with prescription diuretics or lithium, as it can dangerously alter the levels of these drugs in your body. If you are taking blood pressure medication, Pamabrom might cause your blood pressure to drop lower than intended. Additionally, because it is a xanthine derivative, taking it with other stimulants or large amounts of caffeine can lead to increased heart rate and anxiety. Always provide your healthcare provider or pharmacist with a full list of your current medications before starting Pamabrom.
Yes, Pamabrom is widely available as a generic medication and is also a key ingredient in many well-known brand-name OTC products. You can find it as a standalone generic 'diuretic' tablet or as part of combination formulas for menstrual relief. Generic versions are required by the FDA to have the same strength, purity, and effectiveness as the brand-name versions. Choosing a generic option is often a more cost-effective way to manage PMS-related bloating while receiving the same therapeutic benefit as more expensive branded products.
Other drugs with the same active ingredient (Pamabrom)
> Warning: Stop taking Pamabrom and call your doctor immediately if you experience any of these serious symptoms:
Pamabrom is intended for short-term, cyclical use (usually 5-7 days per month). Prolonged, daily use over several months or years is not recommended and can lead to:
There are currently no FDA Black Box Warnings for Pamabrom. It is considered to have a high safety profile when used according to the label instructions for its indicated purpose.
Report any unusual symptoms to your healthcare provider. If you notice any side effects not listed here, contact your pharmacist or the FDA at 1-800-FDA-1088.
For short-term, OTC use, regular lab monitoring is typically not required. However, if your doctor has advised you to take Pamabrom for longer periods or if you have underlying health issues, they may monitor:
Pamabrom generally does not cause drowsiness. However, because it can cause dizziness or lightheadedness in some people (due to fluid shifts), you should see how you react to the medication before driving or operating heavy machinery. If you feel faint or dizzy, sit or lie down immediately.
Alcohol is a natural diuretic and a central nervous system depressant. Combining alcohol with Pamabrom can increase the risk of dehydration and may worsen dizziness or lightheadedness. It is recommended to limit alcohol consumption while using this medication.
There is no need to taper Pamabrom if used for the recommended 5-7 days. If you have been using it daily for a long period (which is not recommended), you should consult a doctor before stopping, as sudden discontinuation might cause temporary 'rebound' water retention.
> Important: Discuss all your medical conditions, especially kidney or heart disease, with your healthcare provider before starting Pamabrom.
For each major interaction, the management strategy usually involves avoiding the combination or having a doctor adjust the dosage of the primary medication. Always maintain a consistent intake of water to mitigate the risk of renal-based interactions.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially if you take medication for blood pressure or mental health.
Patients who are allergic to Caffeine, Theophylline, or Aminophylline should be extremely cautious. These drugs share a similar chemical structure (the xanthine ring). If you have a known allergy to one, your immune system may recognize Pamabrom as a similar threat, leading to a cross-allergic reaction.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of kidney stones or gout, before recommending Pamabrom.
Elderly patients (65 and older) are at a higher risk for adverse effects from diuretics. These include:
In patients with mild to moderate renal impairment, the half-life of Pamabrom is likely extended. There is no specific GFR-based dosing chart, but the frequency of dosing should be reduced (e.g., once or twice daily instead of every 6 hours). It is contraindicated in severe renal failure or anuria.
Since the liver is responsible for the oxidative metabolism of the xanthine component, patients with liver disease (Child-Pugh Class B or C) should be monitored for signs of toxicity. Dose reduction may be necessary to prevent accumulation.
> Important: Special populations require individualized medical assessment. Always consult a specialist if you are pregnant, nursing, or have chronic organ dysfunction.
|---|---|
| Bioavailability | >90% (Oral) |
| Protein Binding | 15% - 40% |
| Half-life | 7 - 10 hours |
| Tmax | 1 - 2 hours |
| Metabolism | Hepatic (Oxidative) |
| Excretion | Renal (>95%) |
Pamabrom is classified as a Xanthine Diuretic. It is in the same therapeutic family as caffeine and theophylline, though it has been chemically modified (brominated) to enhance its diuretic properties while minimizing the central nervous system (CNS) stimulation typically associated with caffeine.